United Therapeutics
Trade United Therapeutics 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About UTHR
United Therapeutics Corp. is a biotechnology company, which engages in the development and commercialization of products for patients with chronic and life-threatening conditions. Its products include Adcirca, Orenitram, Remodulin, TYVASO, and Unituxin.
UTHR Key Statistics
Stock Snapshot
As of today, United Therapeutics(UTHR) shares are valued at $577.40. The company's market cap stands at 25.31B, with a P/E ratio of 20.58.
On 2026-04-22, United Therapeutics(UTHR) stock moved within a range of $572.83 to $580.14. With shares now at $577.40, the stock is trading +0.8% above its intraday low and -0.5% below the session's peak.
Trading volume for United Therapeutics(UTHR) stock has reached 72.37K, versus its average volume of 473.45K.
Over the past 52 weeks, United Therapeutics(UTHR) stock has traded between a high of $607.89 and a low of $272.12.
Over the past 52 weeks, United Therapeutics(UTHR) stock has traded between a high of $607.89 and a low of $272.12.
UTHR News
Image source: The Motley Fool. Wednesday, Feb. 25, 2026 at 9 a.m. ET Call participants Chairperson and Chief Executive Officer — Dr. Martine Rothblatt Presiden...
...
Analyst ratings
76%
of 17 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.